Digestive Diseases

Review Article

Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk

Herszényi L.a · Barabás L.b · Miheller P.a · Tulassay Z.a

Author affiliations

Second Departments of aInternal Medicine and bSurgery, Semmelweis University, Budapest, Hungary

Keywords: Colorectal cancerRisk factorsInflammatory bowel diseaseUlcerative colitisCrohnߣs diseaseSurveillance

Related Articles for ""
Dig Dis 2015;33:52-57
https://doi.org/10.1159/000368447

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Review Article

Published online: December 17, 2014
Issue release date: December 2014

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 1

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Abstract

Patients with long-standing inflammatory bowel disease (IBD) have an increased risk of colorectal cancer (CRC). The association between IBD and CRC is well supported, but reported risk estimates vary widely. Although recent evidence from population-based studies reports a decline in risk, CRC accounts for 10-15% of all deaths in IBD. The potential causes of recent epidemiological trends and the real magnitude of risk of CRC in IBD are subjects of debate. The molecular pathway leading to CRC differs from the classic adenoma-to-CRC sequence. Chronic inflammation contributes to the development of low- and high-grade dysplasia which may further convert into CRC. Patients with a young age at onset, long-standing and extensive colitis with severe inflammatory burden, a family history of sporadic CRC, and concomitant primary sclerosing cholangitis are at greatest risk. The CRC risk in patients with colonic Crohn's disease is similar to that of ulcerative colitis. IBD-associated CRC can frequently be detected at late stages and at a younger age. The long-term prognosis of CRC may be poorer in patients with IBD than in those with sporadic CRC. Regular surveillance colonoscopies may permit earlier detection of CRC, with a corresponding improved prognosis. The interval between surveillance colonoscopies is dependent on each patient's personal risk profile.

© 2014 S. Karger AG, Basel



Related Articles:

References

  1. Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434.
    External Resources
  2. Kucharzik T, Maaser C, Lugering A, Lügering A, Kagnoff M, Mayer L, Targan S, Domschke W: Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis 2006;12:1068-1083.
    External Resources
  3. Abraham C, Medzhitov R: Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011;140:1729-1737.
    External Resources
  4. Lakatos G, Hritz I, Varga MZ, Juhász M, Miheller P, Cierny G, Tulassay Z, Herszényi L: The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Dig Dis 2012;30:289-295.
    External Resources
  5. Crohn B, Rosenberg H: The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am J Med Sci 1925;170:220-228.
  6. Munkholm P: Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003;18(suppl 2):1-5.
    External Resources
  7. Lakatos PL, Lakatos L: Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol 2008;14:3937-3947.
    External Resources
  8. Lukas M: Inflammatory bowel disease as a risk factor for colorectal cancer. Dig Dis 2010;28:619-624.
    External Resources
  9. Herszényi L, Lakatos G, Hritz I, Varga MZ, Cierny G, Tulassay Z: The role of inflammation and proteinases in tumor progression. Dig Dis 2012;30:249-254.
    External Resources
  10. Rogler G: Chronic ulcerative colitis and colorectal cancer. Cancer Lett 2014;345:235-241.
    External Resources
  11. Velayos FS, Ullman TA: Looking forward to understanding and reducing colorectal cancer risk in inflammatory bowel disease. Gastroenterology 2013;145:47-49.
    External Resources
  12. Mehta SJ, Silver AR, Lindsay JO: Review article: strategies for the management of chronic unremitting ulcerative colitis. Aliment Pharmacol Ther 2013;38:77-79.
    External Resources
  13. Seidelin JB, Coskunm M, Nielsen OH: Mucosal healing in ulcerative colitis: pathophysiology and pharmacology. Adv Clin Chem 2013;59:101-123.
    External Resources
  14. Herszényi L, Miheller P, Tulassay Z: Carcinogenesis in inflammatory bowel disease. Dig Dis 2007;25:267-269.
    External Resources
  15. Fujiwara I, Yashiro M, Kubo N, Maeda K, Hirakawa K: Ulcerative colitis-associated colorectal cancer is frequently associated with the microsatellite instability pathway. Dis Colon Rectum 2008;51:1387-1394.
    External Resources
  16. Scarpa M, Castagliuolo I, Castoro C, Pozza A, Scarpa M, Kotsafti A, Angriman I: Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World J Gastroenterol 2014;20:6774-6785.
    External Resources
  17. Allen PB, Kamm MA, De Cruz P, Desmond PV: Dysplastic lesions in ulcerative colitis: changing paradigms. Inflamm Bowel Dis 2010;16:1978-1983.
    External Resources
  18. Rutter MD, Riddell RH: Colorectal dysplasia in inflammatory bowel disease: a clinicopathologic perspective. Clin Gastroenterol Hepatol 2014;12:359-367.
    External Resources
  19. Redston MS, Papadopoulos N, Caldas C, Kinzler KW, Kern SE: Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 1995;108:323-392.
    External Resources
  20. Yoshimi K, Tanaka T, Serikawa T, Kuramoto T: Tumor suppressor APC protein is essential in mucosal repair from colonic inflammation through angiogenesis. Am J Pathol 2013;182:1263-1274.
    External Resources
  21. Lashner BA, Bauer WM, Rybicki LA, Goldblum JR: Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis. Am J Gastroenterol 2003;98:1423-1427.
    External Resources
  22. Goretsky T, Dirisina R, Sinh P, Mittal N, Managlia E, Williams DB, Posca D, Ryu H, Katzman RB, Barrett TA: p53 mediates TNF-induced epithelial cell apoptosis in IBD. Am J Pathol 2012;181:1306-1315.
    External Resources
  23. Kim TO, Park J, Kang MJ, Lee SH, Jee SR, Ryu DY, Yang K, Yi JM: DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis. Int J Mol Med 2013;31:1255-1261.
    External Resources
  24. Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, Lobaton T, Wang A, Boadas J, Piqueras M, Monfort D, Galter S, Esteller M, Moreno V, Capellá G: Novel methylation panel for the early detection of neoplasia in high risk ulcerative colitis and Crohn's colitis patients. Inflamm Bowel Dis 2013;19:165-173.
    External Resources
  25. Azer SA: Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. Eur J Gastroenterol Hepatol 2013;25:271-281.
    External Resources
  26. Papadia C, Louwagie J, Del Rio P, Grooteclaes M, Coruzzi A, Montana C, Novelli M, Bordi C, de' Angelis GL, Bassett P, Bigley J, Warren B, Atkin W, Forbes A: FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia. Inflamm Bowel Dis 2014;20:271-277.
    External Resources
  27. Ryan BM, Wolff RK, Valeri N, Khan M, Robinson D, Paone A, Bowman ED, Lundgreen A, Caan B, Potter J, Brown D, Croce C, Slattery ML, Harris CC: An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. Cancer Epidemiol 2014, Epub ahead of print.
    External Resources
  28. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S; IBD Section of the British Society of Gastroenterology: Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607.
    External Resources
  29. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G: Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 1. Definitions and diagnosis. J Crohns Colitis 2012;6:965-990.
    External Resources
  30. Eaden JA, Abrams KR, Mayberry JF: The true risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gastroenterology 2001;48:526-535.
    External Resources
  31. Jess T, Gamborg M, Matzen P, Munkholm P, Sörensen TI: Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population based cohort studies. Am J Gastroenterol 2005;100:2724-2729.
    External Resources
  32. Canavan C, Abrams KR, Mayberry J: Meta-analysis: colorectal cancer and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006;23:1097-1104.
    External Resources
  33. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP: The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007;50:839-855.
    External Resources
  34. Dyson JK, Rutter MD: Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? World J Gastroenterol 2012;18:3839-3848.
    External Resources
  35. Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M, Fischer S, Vargha P, Lakatos PL: Risk factors of ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006;12:205-211.
    External Resources
  36. Andersen NN, Jess T: Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol 2013;19:7561-7568.
    External Resources
  37. Mooiweer E, Baars JE, Lutgens MW, Vleggaar F, van Oijen M, Siersema PD, Kuipers EJ, van der Woude CJ, Oldenburg B: Disease severity does not affect the interval between IBD diagnosis and the development of CRC: results from two large, Dutch case series. J Crohns Colitis 2012;6:435-440.
    External Resources
  38. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A: Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030-1038.
    External Resources
  39. Söderlund S, Brandt L, Lapidus A, Karlén P, Broström O, Löfberg R, Ekbom A, Askling J: Decreasing time trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009;136:1561-1567.
    External Resources
  40. Winther KV, Jess T, Langholz E, Munkholm P, Binder V: Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004;2:1077-1095.
    External Resources
  41. Jess T, Winther KV, Munkholm P, Langholz E, Binder V: Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 2004;19:287-293.
    External Resources
  42. Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss LS, Lakatos L: Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from western Hungary 1977-2008. J Crohns Colitis 2011;5:122-128.
    External Resources
  43. Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B: Declining risk of colorectal carcinoma in inflammatory bowel disease: an updated meta-analysis of population based cohort studies. Inflamm Bowel Dis 2013;19:789-799.
    External Resources
  44. Peyrin-Biroulet L, Lepage C, Jooste V, Guéant JL, Faivre J, Bouvier AM: Colorectal cancer in inflammatory bowel disease a population-based study (1976-2008). Inflamm Bowel Dis 2012;18:2247-2251.
    External Resources
  45. Beaugerie L, Svrcek M, Seksik P, Bouvier AM, Simon T, Allez M, Brixi H, Gornet JM, Altwegg R, Beau P, Duclos B, Bourreille A, Faivre J, Peyrin-Biroulet L, Fléjou JF, Carrat F; CESAME Study Group: Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013;145:166-175.
    External Resources
  46. Baars JE, Kuipers EJ, van Haastert M, Nicolaï JJ, Poen AC, van der Woude CJ: Age at diagnosis of inflammatory bowel disease early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. J Gastroenterol 2012;47:1308-1322.
    External Resources
  47. Wang R, Leong RW: Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. World J Gastroenterol 2014;20:8783-8789.
    External Resources
  48. Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group: Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer. Gut 2014;63:1416-1423.
    External Resources
  49. Wanders LK, Dekker E, Pullens B, Bassett P, Travis SP, East JE: Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol 2014;12:756-764.
    External Resources
  50. Derikx LA, Kievit W, Drenth JP, de Jong DJ, Ponsioen CY, Oldenburg B, van der Meulen-de Jong AE, Dijkstra G, Grubben MJ, van Laarhoven CJ, Nagtegaal ID, Hoentjen F; Dutch Initiative on Crohn and Colitis: Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease. Gastroenterology 2014;146:119-128.
    External Resources
  51. Grivennikov SI: Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol 2013;35:229-244.
    External Resources
  52. Watanabe T, Konishi T, Kishimoto J, Kotake K, Muto T, Sugihara K; Japanese Society for Cancer of the Colon and Rectum: Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic cancer; a nationwide Japanese study. Inflamm Bowel Dis 2011;17:802-808.
    External Resources
  53. Jensen AB, Larsen M, Gislum M, Skriver MV, Jepsen P, Nörgaard B, Sörensen HT: Survival after colorectal cancer in patients with ulcerative colitis: nationwide population-based Danish study. Am J Gastroenterol 2006;101:1283-1287.
    External Resources
  54. Adams SV, Ahnen DJ, Baron JA, Campbell PT, Gallinger S, Grady WM, LeMarchand L, Lindor NM, Potter JD, Newcomb PA: Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. World J Gastroenterol 2013;19:3241-3248.
    External Resources
  55. Bressenot A, Cahn V, Danese S, Peyrin-Biroulet L: Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol 2014;20:3164-3172.
    External Resources
  56. Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, Beaugerie L, Gomollón F, Häuser W, Herrlinger K, Oldenburg B, Panes J, Portela F, Rogler G, Stein J, Tilg H, Travis S, Lindsay JO: Second European Crohn's and Colitis Organisation: Second European evidence-based consensus on the diagnosis and management of ulcerative colitis. Part 3. Special situations. J Crohns Colitis 2013;7:1-33.
    External Resources
  57. Lutgens M, van Oijen M, Mooiweer E, Valk MV, Vleggaar F, Siersema P, Oldenburg B: A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines. Gastrointest Endosc 2014, Epub ahead of print.
    External Resources
  58. Lutgens M, Vermeire S, Van Oijen M, Vleggaar F, Siersema P, van Assche G, Rutgeerts P, Oldenburg B: A rule of determining risk of colorectal cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2014, Epub ahead of print.
    External Resources
  59. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP: Colonoscopy is associated with a reduced risk of colorectal cancer and mortality in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2014, Epub ahead of print.
    External Resources
  60. Soetikno R, Subramanian V, Kaltenbach T, Rouse RV, Sanduleanu S, Suzuki N, Tanaka S, McQuaid K: The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 2013;144:1349-1352.
    External Resources
  61. Naymagon S, Marion JF: Surveillance in inflammatory bowel disease: chromoendoscopy and digital mucosal enhancement. Gastrointest Endosc Clin N Am 2013;23:679-694.
    External Resources
  62. Rutter MD, Riddell RH: Colorectal neoplasia in inflammatory bowel disease: a clinicopathologic perspective. Clin Gastroenterol Hepatol 2014;12:359-367.
    External Resources
  63. Kwah J, Farraye F: Current and future status for evaluation of dysplasia and carcinoma in IBD. Curr Treat Options Gastroenterol 2014;12:90-102.
    External Resources
  64. Conelly TM, Koltun WA: The cancer ‘fear' in IBD patients: is it still real? J Gastrointest Surg 2014;18:213-218.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Review Article

Published online: December 17, 2014
Issue release date: December 2014

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 1

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2015, Vol.33, No. 1

December 2014

Article

Recommend This
TOP